VectorBuilder
@vectorbuilder.bsky.social
VectorBuilder is a global leader in gene delivery technologies.
If you haven’t had a chance yet, there’s still time to share your feedback and help shape the next wave of VectorBuilder tools and updates. Complete the survey by January 31 to enter for a chance to win up to $1,000 in store credit.
docs.google.com/forms/d/e/1F...
docs.google.com/forms/d/e/1F...
January 15, 2026 at 8:30 PM
If you haven’t had a chance yet, there’s still time to share your feedback and help shape the next wave of VectorBuilder tools and updates. Complete the survey by January 31 to enter for a chance to win up to $1,000 in store credit.
docs.google.com/forms/d/e/1F...
docs.google.com/forms/d/e/1F...
Reminder! Don’t miss our seminar with Dr. Cristina Martinez Gonzalez as she introduces novel tissue-clearing strategies and key considerations for selecting the right protocol for different samples and research objectives.
Register here! us06web.zoom.us/webinar/regi...
Register here! us06web.zoom.us/webinar/regi...
Interested in tissue-clearing techniques to study intact samples in 3D? Catch Dr. Cristina Martinez Gonzalez's talk (@cristina-mtz-glz.bsky.social) as she introduces novel tissue-clearing strategies & key considerations for selecting the right protocol for different samples & research objectives.
January 14, 2026 at 3:50 PM
Reminder! Don’t miss our seminar with Dr. Cristina Martinez Gonzalez as she introduces novel tissue-clearing strategies and key considerations for selecting the right protocol for different samples and research objectives.
Register here! us06web.zoom.us/webinar/regi...
Register here! us06web.zoom.us/webinar/regi...
New study from the Torkamaneh lab @ulaval.ca uses CRISPR knockouts to show how nitrogen fixation & root development are genetically linked in soybean.
CRISPR‐induced knockouts reveal a dual role for the soybean NFR5α gene in symbiotic nitrogen fixation and root hair development
Nitrogen fixation in soybeans, facilitated by symbiotic interactions with rhizobia, is a cornerstone of sustainable agriculture, reducing reliance on synthetic fertilizers. However, the efficiency of...
acsess.onlinelibrary.wiley.com
January 13, 2026 at 3:06 PM
New study from the Torkamaneh lab @ulaval.ca uses CRISPR knockouts to show how nitrogen fixation & root development are genetically linked in soybean.
Interested in tissue-clearing techniques to study intact samples in 3D? Catch Dr. Cristina Martinez Gonzalez's talk (@cristina-mtz-glz.bsky.social) as she introduces novel tissue-clearing strategies & key considerations for selecting the right protocol for different samples & research objectives.
January 9, 2026 at 4:45 PM
Interested in tissue-clearing techniques to study intact samples in 3D? Catch Dr. Cristina Martinez Gonzalez's talk (@cristina-mtz-glz.bsky.social) as she introduces novel tissue-clearing strategies & key considerations for selecting the right protocol for different samples & research objectives.
📣 Share Your Thoughts and Boost Your Research!
Our Annual User Survey is now live, and we’d love to hear from you. Your feedback directly helps us improve the tools, services, and support that power your research, including VectorBee upgrades.
Our Annual User Survey is now live, and we’d love to hear from you. Your feedback directly helps us improve the tools, services, and support that power your research, including VectorBee upgrades.
January 8, 2026 at 5:11 PM
📣 Share Your Thoughts and Boost Your Research!
Our Annual User Survey is now live, and we’d love to hear from you. Your feedback directly helps us improve the tools, services, and support that power your research, including VectorBee upgrades.
Our Annual User Survey is now live, and we’d love to hear from you. Your feedback directly helps us improve the tools, services, and support that power your research, including VectorBee upgrades.
In a new Forbes commentary, our COO, Kristofer Mussar, reflects on what customer support looks like in the age of AI and why automation alone isn’t enough.
Read the full piece to learn how balancing technology and humanity can build real trust: www.forbes.com/councils/for...
Read the full piece to learn how balancing technology and humanity can build real trust: www.forbes.com/councils/for...
www.forbes.com
January 7, 2026 at 4:17 PM
In a new Forbes commentary, our COO, Kristofer Mussar, reflects on what customer support looks like in the age of AI and why automation alone isn’t enough.
Read the full piece to learn how balancing technology and humanity can build real trust: www.forbes.com/councils/for...
Read the full piece to learn how balancing technology and humanity can build real trust: www.forbes.com/councils/for...
VectorBuilder has partnered with UK-based Ikarovec Ltd in an exclusive collaboration to advance a promising one-time dual pathway gene therapy for intermediate age-related macular degeneration, a condition with no currently approved treatment options.
January 6, 2026 at 3:45 PM
VectorBuilder has partnered with UK-based Ikarovec Ltd in an exclusive collaboration to advance a promising one-time dual pathway gene therapy for intermediate age-related macular degeneration, a condition with no currently approved treatment options.
Lights are back on, lab benches are ready, & science is officially back in motion. We hope you had time to rest, reset, & maybe even let a few ideas incubate over the break. We’re ready to support your next experiments & discoveries. Here’s to fresh hypotheses & meaningful results in the year ahead!
January 5, 2026 at 6:49 PM
Lights are back on, lab benches are ready, & science is officially back in motion. We hope you had time to rest, reset, & maybe even let a few ideas incubate over the break. We’re ready to support your next experiments & discoveries. Here’s to fresh hypotheses & meaningful results in the year ahead!
In 2025, VectorBuilder went worldwide 🌍🧬
From lab benches to conference halls across the globe, our team connected with researchers sharing ideas, sparking collaborations, and accelerating discovery. Different cities, different time zones, one mission: pushing science forward, wherever it happens.
From lab benches to conference halls across the globe, our team connected with researchers sharing ideas, sparking collaborations, and accelerating discovery. Different cities, different time zones, one mission: pushing science forward, wherever it happens.
December 31, 2025 at 8:52 PM
In 2025, VectorBuilder went worldwide 🌍🧬
From lab benches to conference halls across the globe, our team connected with researchers sharing ideas, sparking collaborations, and accelerating discovery. Different cities, different time zones, one mission: pushing science forward, wherever it happens.
From lab benches to conference halls across the globe, our team connected with researchers sharing ideas, sparking collaborations, and accelerating discovery. Different cities, different time zones, one mission: pushing science forward, wherever it happens.
In 2025, VectorBuilder’s Gene Delivery Seminar Series brought together expert insights, emerging technologies, and practical solutions from across the field. Thanks to our speakers and community for joining us. More to come in 2026!
December 30, 2025 at 5:42 PM
In 2025, VectorBuilder’s Gene Delivery Seminar Series brought together expert insights, emerging technologies, and practical solutions from across the field. Thanks to our speakers and community for joining us. More to come in 2026!
As the year winds down and experiments pause, we’re grateful for the scientists, collaborators, and innovators who made 2025 a great year. Thank you for building the future of science!
December 23, 2025 at 5:09 PM
As the year winds down and experiments pause, we’re grateful for the scientists, collaborators, and innovators who made 2025 a great year. Thank you for building the future of science!
Season’s Greetings from the VectorBuilder team! 🎄
Our holiday party was proof that great science comes with even better people. Fun conversations, lots of laughs, and some of the people who make it all happen ✨
Our holiday party was proof that great science comes with even better people. Fun conversations, lots of laughs, and some of the people who make it all happen ✨
December 22, 2025 at 7:05 PM
Season’s Greetings from the VectorBuilder team! 🎄
Our holiday party was proof that great science comes with even better people. Fun conversations, lots of laughs, and some of the people who make it all happen ✨
Our holiday party was proof that great science comes with even better people. Fun conversations, lots of laughs, and some of the people who make it all happen ✨
Missed last week's seminar?
Dr. Cat Saunders (Senior Applications Specialist at SPARTA Biodiscovery) introduces best practices in nanoparticle characterization, highlighting why consistent, reliable measurement is essential for understanding drug loading, composition, heterogeneity, and stability.
Dr. Cat Saunders (Senior Applications Specialist at SPARTA Biodiscovery) introduces best practices in nanoparticle characterization, highlighting why consistent, reliable measurement is essential for understanding drug loading, composition, heterogeneity, and stability.
December 19, 2025 at 6:09 PM
Missed last week's seminar?
Dr. Cat Saunders (Senior Applications Specialist at SPARTA Biodiscovery) introduces best practices in nanoparticle characterization, highlighting why consistent, reliable measurement is essential for understanding drug loading, composition, heterogeneity, and stability.
Dr. Cat Saunders (Senior Applications Specialist at SPARTA Biodiscovery) introduces best practices in nanoparticle characterization, highlighting why consistent, reliable measurement is essential for understanding drug loading, composition, heterogeneity, and stability.
A little holiday surprise showed up under the VectorBuilder tree 🎄
We’re excited to share that VectorBuilder was named LSSM Marketing Team of the Year. Grateful for this team and the scientific community that inspires our work!
We’re excited to share that VectorBuilder was named LSSM Marketing Team of the Year. Grateful for this team and the scientific community that inspires our work!
December 18, 2025 at 7:49 PM
A little holiday surprise showed up under the VectorBuilder tree 🎄
We’re excited to share that VectorBuilder was named LSSM Marketing Team of the Year. Grateful for this team and the scientific community that inspires our work!
We’re excited to share that VectorBuilder was named LSSM Marketing Team of the Year. Grateful for this team and the scientific community that inspires our work!
Earlier this year, Dr. Katherine Sadleir and the Vassar lab showed that annexin A6 localizes to dystrophic neurites and reduces neurite burden and phosphorylated tau in AD model mice, supporting further investigation of rA6 to limit Aβ-induced membrane damage.
December 17, 2025 at 9:24 PM
Earlier this year, Dr. Katherine Sadleir and the Vassar lab showed that annexin A6 localizes to dystrophic neurites and reduces neurite burden and phosphorylated tau in AD model mice, supporting further investigation of rA6 to limit Aβ-induced membrane damage.
At VectorBuilder, we're proud to build lasting partnerships in science. Thank you to Dr. Angelina Palacios Muñoz from Universidad de Valparaíso (Chile) for this testimonial. We love to hear how our team has helped and supported your research breakthroughs throughout this year!
December 15, 2025 at 7:16 PM
At VectorBuilder, we're proud to build lasting partnerships in science. Thank you to Dr. Angelina Palacios Muñoz from Universidad de Valparaíso (Chile) for this testimonial. We love to hear how our team has helped and supported your research breakthroughs throughout this year!
Don't miss! Our seminar with Dr. Cat Saunders (Senior Applications Specialist at SPARTA Biodiscovery) starts today!
Join the webinar here:
us06web.zoom.us/webinar/regi...
Join the webinar here:
us06web.zoom.us/webinar/regi...
December 11, 2025 at 3:21 PM
Don't miss! Our seminar with Dr. Cat Saunders (Senior Applications Specialist at SPARTA Biodiscovery) starts today!
Join the webinar here:
us06web.zoom.us/webinar/regi...
Join the webinar here:
us06web.zoom.us/webinar/regi...
We had a great time connecting with you all at #CellBio2025!
Missed us and our cool swag at Cell Bio? No problem! Reach out to our team and we'll send you our VectorBuilder 2026 calendars on your next order!
Thank you @ascbiology.bsky.social and @embo.org for having us, and see you next year!
Missed us and our cool swag at Cell Bio? No problem! Reach out to our team and we'll send you our VectorBuilder 2026 calendars on your next order!
Thank you @ascbiology.bsky.social and @embo.org for having us, and see you next year!
December 10, 2025 at 7:59 PM
We had a great time connecting with you all at #CellBio2025!
Missed us and our cool swag at Cell Bio? No problem! Reach out to our team and we'll send you our VectorBuilder 2026 calendars on your next order!
Thank you @ascbiology.bsky.social and @embo.org for having us, and see you next year!
Missed us and our cool swag at Cell Bio? No problem! Reach out to our team and we'll send you our VectorBuilder 2026 calendars on your next order!
Thank you @ascbiology.bsky.social and @embo.org for having us, and see you next year!
Curious to see what it really takes to bring your research to the drug development stage? 🧬
Our last Gene Delivery Seminar featured Dr. Andy Merritt, Head of Academic Engagement at LifeArc, as he explored the scientific, financial, and societal drivers behind the process.
Our last Gene Delivery Seminar featured Dr. Andy Merritt, Head of Academic Engagement at LifeArc, as he explored the scientific, financial, and societal drivers behind the process.
December 9, 2025 at 10:17 PM
Curious to see what it really takes to bring your research to the drug development stage? 🧬
Our last Gene Delivery Seminar featured Dr. Andy Merritt, Head of Academic Engagement at LifeArc, as he explored the scientific, financial, and societal drivers behind the process.
Our last Gene Delivery Seminar featured Dr. Andy Merritt, Head of Academic Engagement at LifeArc, as he explored the scientific, financial, and societal drivers behind the process.
New SelectScience article featuring insights from Dr. Alan Griffith, VectorBuilder’s Head of CDMO Operations, on why mechanism of action (MoA)-based potency assays are essential for successful gene therapy development.
A great read for anyone advancing gene therapy programs.
A great read for anyone advancing gene therapy programs.
Mechanism-linked potency assays drive gene therapy success
VectorBuilder’s Alan Griffith explains the value of MoA-reflective potency assays for gene therapy development and the benefits of working with assay specialists like Svar Life Science
www.selectscience.net
December 8, 2025 at 7:22 PM
New SelectScience article featuring insights from Dr. Alan Griffith, VectorBuilder’s Head of CDMO Operations, on why mechanism of action (MoA)-based potency assays are essential for successful gene therapy development.
A great read for anyone advancing gene therapy programs.
A great read for anyone advancing gene therapy programs.
Attending #CellBio2025? Stop by our Booth #307 and chat with our team to learn about our latest offerings and solutions for your research needs. Be sure to also catch our presentation, "Optimizing lentiviral vector design and production for cell and gene therapies" at Board B488. See you there!
December 5, 2025 at 7:22 PM
Attending #CellBio2025? Stop by our Booth #307 and chat with our team to learn about our latest offerings and solutions for your research needs. Be sure to also catch our presentation, "Optimizing lentiviral vector design and production for cell and gene therapies" at Board B488. See you there!
Congrats to Dr. Zinia Mohanta and the McMahon Lab! Their new study shows the first in vivo use of a genetically encoded CEST MRI reporter delivered by rAAV. superCESTide enabled non-invasive, dose-dependent imaging of transgene expression, bringing in vivo gene expression into clear view.
December 4, 2025 at 6:34 PM
Congrats to Dr. Zinia Mohanta and the McMahon Lab! Their new study shows the first in vivo use of a genetically encoded CEST MRI reporter delivered by rAAV. superCESTide enabled non-invasive, dose-dependent imaging of transgene expression, bringing in vivo gene expression into clear view.
Reminder! Join us next week for a seminar with Dr. @Cat Saunders (Senior Applications Specialist at @SPARTA Biodiscovery) introducing a first-in-class, label-free platform for single-particle characterization, SPARTA®.
Register here! us06web.zoom.us/webinar/regi...
Register here! us06web.zoom.us/webinar/regi...
Working in drug delivery, gene therapy, or nanoparticle formulation? Our December Gene Deliver Seminar with SPARTA Biodiscovery is for you!
Register here! us06web.zoom.us/webinar/regi...
Register here! us06web.zoom.us/webinar/regi...
December 3, 2025 at 6:38 PM
Reminder! Join us next week for a seminar with Dr. @Cat Saunders (Senior Applications Specialist at @SPARTA Biodiscovery) introducing a first-in-class, label-free platform for single-particle characterization, SPARTA®.
Register here! us06web.zoom.us/webinar/regi...
Register here! us06web.zoom.us/webinar/regi...
This December, the VectorBuilder team will be going to several key conferences around the world! Don't miss us at the upcoming conferences!
December 2, 2025 at 5:27 PM
This December, the VectorBuilder team will be going to several key conferences around the world! Don't miss us at the upcoming conferences!
On #WorldAIDSDay, we highlight research advancing HIV prevention & treatment.
A study from the Kula-Pacurar lab at Małopolska Centre of Biotechnology introduces a dual-fluorescent HIV-1 reporter system that measures a key step in viral replication & could support discovery of new HIV therapeutics.
A study from the Kula-Pacurar lab at Małopolska Centre of Biotechnology introduces a dual-fluorescent HIV-1 reporter system that measures a key step in viral replication & could support discovery of new HIV therapeutics.
December 1, 2025 at 7:36 PM
On #WorldAIDSDay, we highlight research advancing HIV prevention & treatment.
A study from the Kula-Pacurar lab at Małopolska Centre of Biotechnology introduces a dual-fluorescent HIV-1 reporter system that measures a key step in viral replication & could support discovery of new HIV therapeutics.
A study from the Kula-Pacurar lab at Małopolska Centre of Biotechnology introduces a dual-fluorescent HIV-1 reporter system that measures a key step in viral replication & could support discovery of new HIV therapeutics.